APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leber's Hereditary Optic Neuropathy Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Leber's Hereditary Optic Neuropathy Drug Market Analysis and Forecast 2026-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchLeber's Hereditary Optic Neuropathy Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Leber's Hereditary Optic Neuropathy Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Leber's Hereditary Optic Neuropathy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leber's Hereditary Optic Neuropathy Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Leber's Hereditary Optic Neuropathy Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Leber's Hereditary Optic Neuropathy Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Leber's Hereditary Optic Neuropathy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Leber's Hereditary Optic Neuropathy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Leber's Hereditary Optic Neuropathy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Leber's Hereditary Optic Neuropathy Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Leber's Hereditary Optic Neuropathy Drug include Stealth BioTherapeutics Inc., Spark Therapeutics, Inc., Khondrion BV, Ixchel Pharma, LLC, GenSight Biologics S.A., Biovista Inc. and Alkeus Pharmaceuticals, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Leber's Hereditary Optic Neuropathy Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Leber's Hereditary Optic Neuropathy Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Leber's Hereditary Optic Neuropathy Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Leber's Hereditary Optic Neuropathy Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Leber's Hereditary Optic Neuropathy Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Leber's Hereditary Optic Neuropathy Drug sales, projected growth trends, production technology, application and end-user industry.

Leber's Hereditary Optic Neuropathy Drug Segment by Company

Stealth BioTherapeutics Inc.

Spark Therapeutics, Inc.

Khondrion BV

Ixchel Pharma, LLC

GenSight Biologics S.A.

Biovista Inc.

Alkeus Pharmaceuticals, Inc.

Leber's Hereditary Optic Neuropathy Drug Segment by Type

Elamipretide

KH-176

IXC-201

GS-011

Others

Leber's Hereditary Optic Neuropathy Drug Segment by Application

Hospital

Clinic

Others

Leber's Hereditary Optic Neuropathy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leber's Hereditary Optic Neuropathy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leber's Hereditary Optic Neuropathy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leber's Hereditary Optic Neuropathy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Leber's Hereditary Optic Neuropathy Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Leber's Hereditary Optic Neuropathy Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leber's Hereditary Optic Neuropathy Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Elamipretide Major Manufacturers Table 3. KH-176 Major Manufacturers Table 4. IXC-201 Major Manufacturers Table 5. GS-011 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Leber's Hereditary Optic Neuropathy Drug Industry Trends Table 12. Leber's Hereditary Optic Neuropathy Drug Industry Drivers Table 13. Leber's Hereditary Optic Neuropathy Drug Industry Opportunities and Challenges Table 14. Leber's Hereditary Optic Neuropathy Drug Industry Restraints Table 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2021-2026) Table 19. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2027-2032) Table 20. Global Leber's Hereditary Optic Neuropathy Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2021-2026) Table 24. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2027-2032) Table 25. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Leber's Hereditary Optic Neuropathy Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Leber's Hereditary Optic Neuropathy Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Leber's Hereditary Optic Neuropathy Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers, Product Type & Application Table 33. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Leber's Hereditary Optic Neuropathy Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2021-2026) Table 40. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2027-2032) Table 41. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2021-2026) Table 45. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2027-2032) Table 46. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Leber's Hereditary Optic Neuropathy Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2021-2026) Table 52. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2027-2032) Table 53. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2021-2026) Table 57. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2027-2032) Table 58. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Leber's Hereditary Optic Neuropathy Drug Price by Application (2027-2032) & (US$/Unit) Table 60. Stealth BioTherapeutics Inc. Company Information Table 61. Stealth BioTherapeutics Inc. Business Overview Table 62. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 64. Stealth BioTherapeutics Inc. Recent Development Table 65. Spark Therapeutics, Inc. Company Information Table 66. Spark Therapeutics, Inc. Business Overview Table 67. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 69. Spark Therapeutics, Inc. Recent Development Table 70. Khondrion BV Company Information Table 71. Khondrion BV Business Overview Table 72. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 74. Khondrion BV Recent Development Table 75. Ixchel Pharma, LLC Company Information Table 76. Ixchel Pharma, LLC Business Overview Table 77. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 79. Ixchel Pharma, LLC Recent Development Table 80. GenSight Biologics S.A. Company Information Table 81. GenSight Biologics S.A. Business Overview Table 82. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 84. GenSight Biologics S.A. Recent Development Table 85. Biovista Inc. Company Information Table 86. Biovista Inc. Business Overview Table 87. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 89. Biovista Inc. Recent Development Table 90. Alkeus Pharmaceuticals, Inc. Company Information Table 91. Alkeus Pharmaceuticals, Inc. Business Overview Table 92. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio Table 94. Alkeus Pharmaceuticals, Inc. Recent Development Table 95. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 98. North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 99. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 100. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 101. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 104. North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 105. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 106. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 107. North America Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Units) Table 112. North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2027-2032) & (K Units) Table 113. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 114. North America Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 115. United States Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 116. Canada Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 117. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 120. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 121. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 122. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 123. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 126. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 127. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 128. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 129. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Units) Table 134. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2027-2032) & (K Units) Table 135. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 136. Europe Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 137. Germany Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 138. France Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 139. U.K. Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 140. Italy Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 142. China Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. China Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. China Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 145. China Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 146. China Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 147. China Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 148. China Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. China Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. China Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 151. China Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 152. China Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 153. China Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 157. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 158. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 163. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 164. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 170. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Units) Table 171. Asia Leber's Hereditary Optic Neuropathy Drug Sales by Country (2027-2032) & (K Units) Table 172. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Asia Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Japan Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 175. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 176. India Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 177. Australia Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 178. China Taiwan Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 179. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 180. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2026) & (US$ Million) Table 181. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2027-2032) & (US$ Million) Table 182. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2026) & (K Units) Table 183. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Type (2027-2032) & (K Units) Table 184. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 185. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 186. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2026) & (US$ Million) Table 187. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2027-2032) & (US$ Million) Table 188. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2026) & (K Units) Table 189. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Application (2027-2032) & (K Units) Table 190. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 191. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 192. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021-2026) & (K Units) Table 197. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Country (2027-2032) & (K Units) Table 198. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 199. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 201. Argentina Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 202. Chile Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 203. Colombia Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 204. Peru Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 205. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 206. Israel Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 207. UAE Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 208. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 209. Iran Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 210. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Leber's Hereditary Optic Neuropathy Drug Distributors List Table 214. Leber's Hereditary Optic Neuropathy Drug Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Leber's Hereditary Optic Neuropathy Drug Image Figure 2. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leber's Hereditary Optic Neuropathy Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Elamipretide Image Figure 5. KH-176 Image Figure 6. IXC-201 Image Figure 7. GS-011 Image Figure 8. Others Image Figure 9. Global Leber's Hereditary Optic Neuropathy Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Leber's Hereditary Optic Neuropathy Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Leber's Hereditary Optic Neuropathy Drug Sales (2021-2032) & (K Units) Figure 20. Global Leber's Hereditary Optic Neuropathy Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Leber's Hereditary Optic Neuropathy Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Leber's Hereditary Optic Neuropathy Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Leber's Hereditary Optic Neuropathy Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Leber's Hereditary Optic Neuropathy Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2021-2032) Figure 36. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2021-2032) Figure 42. North America Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2021-2032) Figure 43. North America Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2021-2032) Figure 44. North America Leber's Hereditary Optic Neuropathy Drug Revenue Share by Application (2021-2032) Figure 45. North America Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2021-2032) Figure 46. North America Leber's Hereditary Optic Neuropathy Drug Revenue Share by Country (2021-2032) Figure 47. North America Leber's Hereditary Optic Neuropathy Drug Sales Share by Country (2021-2032) Figure 48. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2021-2032) Figure 49. Europe Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2021-2032) Figure 50. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Share by Application (2021-2032) Figure 51. Europe Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2021-2032) Figure 52. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Share by Country (2021-2032) Figure 53. Europe Leber's Hereditary Optic Neuropathy Drug Sales Share by Country (2021-2032) Figure 54. China Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2021-2032) Figure 55. China Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2021-2032) Figure 56. China Leber's Hereditary Optic Neuropathy Drug Revenue Share by Application (2021-2032) Figure 57. China Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2021-2032) Figure 58. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2021-2032) Figure 59. Asia Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2021-2032) Figure 60. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Share by Application (2021-2032) Figure 61. Asia Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2021-2032) Figure 62. Asia Leber's Hereditary Optic Neuropathy Drug Revenue Share by Country (2021-2032) Figure 63. Asia Leber's Hereditary Optic Neuropathy Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Leber's Hereditary Optic Neuropathy Drug Sales Share by Country (2021-2032) Figure 70. Leber's Hereditary Optic Neuropathy Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Leber's Hereditary Optic Neuropathy Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Elamipretide
  • KH-176
  • IXC-201
  • GS-011
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Stealth BioTherapeutics Inc.
  • Spark Therapeutics, Inc.
  • Khondrion BV
  • Ixchel Pharma, LLC
  • GenSight Biologics S.A.
  • Biovista Inc.
  • Alkeus Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Leber's Hereditary Optic Neuropathy Drug Market by Type
  3. 1.2.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Elamipretide
  5. 1.2.3 KH-176
  6. 1.2.4 IXC-201
  7. 1.2.5 GS-011
  8. 1.2.6 Others
  9. 1.3 Leber's Hereditary Optic Neuropathy Drug Market by Application
  10. 1.3.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Leber's Hereditary Optic Neuropathy Drug Market Dynamics
  1. 2.1 Leber's Hereditary Optic Neuropathy Drug Industry Trends
  2. 2.2 Leber's Hereditary Optic Neuropathy Drug Industry Drivers
  3. 2.3 Leber's Hereditary Optic Neuropathy Drug Industry Opportunities and Challenges
  4. 2.4 Leber's Hereditary Optic Neuropathy Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region
  3. 3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region
  9. 3.4.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Leber's Hereditary Optic Neuropathy Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturers
  2. 4.1.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturers
  6. 4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Leber's Hereditary Optic Neuropathy Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Leber's Hereditary Optic Neuropathy Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Leber's Hereditary Optic Neuropathy Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Leber's Hereditary Optic Neuropathy Drug Manufacturers, Product Type & Application
  13. 4.7 Global Leber's Hereditary Optic Neuropathy Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Leber's Hereditary Optic Neuropathy Drug Market CR5 and HHI
  16. 4.8.2 2025 Leber's Hereditary Optic Neuropathy Drug Tier 1, Tier 2, and Tier 3
5 Leber's Hereditary Optic Neuropathy Drug Market by Type
  1. 5.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type
  2. 5.1.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type
  6. 5.2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Leber's Hereditary Optic Neuropathy Drug Price by Type
6 Leber's Hereditary Optic Neuropathy Drug Market by Application
  1. 6.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application
  2. 6.1.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application
  6. 6.2.1 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Leber's Hereditary Optic Neuropathy Drug Price by Application
7 Company Profiles
  1. 7.1 Stealth BioTherapeutics Inc.
  2. 7.1.1 Stealth BioTherapeutics Inc. Company Information
  3. 7.1.2 Stealth BioTherapeutics Inc. Business Overview
  4. 7.1.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  6. 7.1.5 Stealth BioTherapeutics Inc. Recent Developments
  7. 7.2 Spark Therapeutics, Inc.
  8. 7.2.1 Spark Therapeutics, Inc. Company Information
  9. 7.2.2 Spark Therapeutics, Inc. Business Overview
  10. 7.2.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  12. 7.2.5 Spark Therapeutics, Inc. Recent Developments
  13. 7.3 Khondrion BV
  14. 7.3.1 Khondrion BV Company Information
  15. 7.3.2 Khondrion BV Business Overview
  16. 7.3.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  18. 7.3.5 Khondrion BV Recent Developments
  19. 7.4 Ixchel Pharma, LLC
  20. 7.4.1 Ixchel Pharma, LLC Company Information
  21. 7.4.2 Ixchel Pharma, LLC Business Overview
  22. 7.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  24. 7.4.5 Ixchel Pharma, LLC Recent Developments
  25. 7.5 GenSight Biologics S.A.
  26. 7.5.1 GenSight Biologics S.A. Company Information
  27. 7.5.2 GenSight Biologics S.A. Business Overview
  28. 7.5.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  30. 7.5.5 GenSight Biologics S.A. Recent Developments
  31. 7.6 Biovista Inc.
  32. 7.6.1 Biovista Inc. Company Information
  33. 7.6.2 Biovista Inc. Business Overview
  34. 7.6.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  36. 7.6.5 Biovista Inc. Recent Developments
  37. 7.7 Alkeus Pharmaceuticals, Inc.
  38. 7.7.1 Alkeus Pharmaceuticals, Inc. Company Information
  39. 7.7.2 Alkeus Pharmaceuticals, Inc. Business Overview
  40. 7.7.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolio
  42. 7.7.5 Alkeus Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Leber's Hereditary Optic Neuropathy Drug Market Size by Type
  2. 8.1.1 North America Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2032)
  5. 8.2 North America Leber's Hereditary Optic Neuropathy Drug Market Size by Application
  6. 8.2.1 North America Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2032)
  9. 8.3 North America Leber's Hereditary Optic Neuropathy Drug Market Size by Country
  10. 8.3.1 North America Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Leber's Hereditary Optic Neuropathy Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Leber's Hereditary Optic Neuropathy Drug Market Size by Type
  2. 9.1.1 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2032)
  5. 9.2 Europe Leber's Hereditary Optic Neuropathy Drug Market Size by Application
  6. 9.2.1 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2032)
  9. 9.3 Europe Leber's Hereditary Optic Neuropathy Drug Market Size by Country
  10. 9.3.1 Europe Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Leber's Hereditary Optic Neuropathy Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Leber's Hereditary Optic Neuropathy Drug Market Size by Type
  2. 10.1.1 China Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032)
  4. 10.1.3 China Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2032)
  5. 10.2 China Leber's Hereditary Optic Neuropathy Drug Market Size by Application
  6. 10.2.1 China Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032)
  8. 10.2.3 China Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Leber's Hereditary Optic Neuropathy Drug Market Size by Type
  2. 11.1.1 Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2032)
  5. 11.2 Asia Leber's Hereditary Optic Neuropathy Drug Market Size by Application
  6. 11.2.1 Asia Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2032)
  9. 11.3 Asia Leber's Hereditary Optic Neuropathy Drug Market Size by Country
  10. 11.3.1 Asia Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Leber's Hereditary Optic Neuropathy Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Leber's Hereditary Optic Neuropathy Drug Market Size by Type
  2. 12.1.1 SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Leber's Hereditary Optic Neuropathy Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Leber's Hereditary Optic Neuropathy Drug Market Size by Application
  6. 12.2.1 SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Leber's Hereditary Optic Neuropathy Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Leber's Hereditary Optic Neuropathy Drug Market Size by Country
  10. 12.3.1 SAMEA Leber's Hereditary Optic Neuropathy Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Leber's Hereditary Optic Neuropathy Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Leber's Hereditary Optic Neuropathy Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Leber's Hereditary Optic Neuropathy Drug Value Chain Analysis
  2. 13.1.1 Leber's Hereditary Optic Neuropathy Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Leber's Hereditary Optic Neuropathy Drug Production Mode & Process
  6. 13.2 Leber's Hereditary Optic Neuropathy Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Leber's Hereditary Optic Neuropathy Drug Distributors
  9. 13.2.3 Leber's Hereditary Optic Neuropathy Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst